Log in or Sign up for Free to view tailored content for your specialty!
Endocrinology News
‘Future of treating MASH’ will combine GLP-1 drugs, liver-specific medications
Metabolic dysfunction-associated steatotic liver disease is a public health threat, affecting 30% to 38% of the adult population globally. The prevalence has risen in parallel with epidemics of obesity and type 2 diabetes.
Manage lifestyle early and aggressively to prevent, instead of treat, fatty liver
Millions of dollars have been spent trying to find medications that could treat this complex disorder. The focus has been on drugs for more severe disease, as it leads to complications, and early stages have been somewhat ignored.
Log in or Sign up for Free to view tailored content for your specialty!
Consider today’s options for covering the future cost of long-term care
As their parents age, many of our physician clients have asked us about long-term care insurance.
Risk tools do not outperform BMD for predicting hip fractures among late-life adults
Two fracture risk assessment tools incorporating femoral neck bone mineral density did not outperform femoral neck BMD alone for predicting hip fractures among adults aged 80 years and older, according to study data.
Delaying diabetes through diet, exercise for 4 years reduces risk for death
People who delayed diabetes through diet and exercise for at least 4 years after their prediabetes diagnosis had a lower risk for death and other adverse outcomes vs. those who were diagnosed with diabetes during that time, a study showed.
Combined SGLT2 and GLP-1 therapy lowers risk for CVD, kidney disease in type 2 diabetes
Combined SGLT2 inhibitor and GLP-1 receptor agonist therapy could provide additional cardiovascular and renal benefits for adults with type 2 diabetes, according to data from a meta-analysis published in The Lancet Diabetes & Endocrinology.
CMS proposes cutting physician payments for fifth straight year
CMS has released its proposed 2025 Medicare Physician Fee Schedule, or PFS, which includes a 2.93% cut in physician payments from the previous year, according to a press release.
FDA rejects once-weekly basal insulin for diabetes, requests more information
The FDA declined to approve once-weekly basal insulin icodec for the treatment of diabetes and is requesting more information from Novo Nordisk, according to a company press release.
Nearly half of cancer deaths among U.S. adults attributable to modifiable risk factors
About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.
AI model highly accurate in determining malignancy of thyroid nodule images
An AI model achieved higher accuracy than three cytopathologists for determining malignancy in a large dataset of image patches of thyroid fine-needle aspiration whole-slide images, according to a study published in Thyroid.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read